This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Mystakidou K, Katsouda E, Tsilika E, Smyrniotis V, Vassiliou I, Tsiatas M, Vlahos L.Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment. Anticancer Research 26: 2325-2328, No. 3, May-Jun 2006
About this article
Cite this article
The use of long-acting octreotide improves quality of life (QOL) in patients with cancer who have loperamide-refractory diarrhoea,. Pharmacoecon. Outcomes News 509, 9 (2006). https://doi.org/10.2165/00151234-200605090-00026
- Public Health
- Health Outcome
- Energy Level
- Medical Intervention
- Analog Scale